Eyenovia Announces $15 Million Credit Facility with Avenue Venture Debt Fund

Author's Avatar
Nov 29, 2022

Transaction proceeds, together with cash on-hand, expected to fund operations through late 2023/early 2024, including potential FDA approval of MydCombi™